Earnings summaries and quarterly performance for NEOGEN.
Executive leadership at NEOGEN.
Board of directors at NEOGEN.
Research analysts who have asked questions during NEOGEN earnings calls.
Brandon Vazquez
William Blair & Company, L.L.C.
6 questions for NEOG
Also covers: ALGN, CBLL, CVRX +16 more
David Westenberg
Piper Sandler
6 questions for NEOG
Also covers: ADPT, AKYA, BLLN +13 more
Subbu Nambi
Guggenheim Securities
3 questions for NEOG
Also covers: BOLD, BRKR, CARS +16 more
Tom DeBourcy
Nephron Research LLC
3 questions for NEOG
Also covers: CDNA, RGEN, TECH +2 more
Bob Labick
CJS Securities
2 questions for NEOG
Also covers: ACVA, BCPC, BV +10 more
Subhalaxmi Nambi
Guggenheim Securities
2 questions for NEOG
Also covers: AKYA, BRKR, CSTL +15 more
Thomas DeBourcy
Nephron Research
2 questions for NEOG
Also covers: CDNA, QTRX, TWST +2 more
Recent press releases and 8-K filings for NEOG.
Neogen Reports Q1 FY26 Results
NEOG
Earnings
Guidance Update
Layoffs
- NEOG's Q1 FY26 performance was in line with expectations, reporting revenue of $209.2 million and Adjusted EBITDA of $35.5 million.
- The company implemented a cost-reduction initiative with expected annualized savings of $20 million and paid down $100 million of debt following the Cleaners & Disinfectants divestiture.
- The full-year FY26 outlook was reaffirmed, with projected revenue between $820 million and $840 million and Adjusted EBITDA between $165 million and $175 million.
- Strategic actions include a ~10% headcount reduction and a focus on accelerating top-line growth, operational excellence, and reinvigorating innovation.
Oct 9, 2025, 12:00 PM
Neogen Reports Q1 2026 Results and Outlines Strategic Priorities
NEOG
Earnings
Guidance Update
Layoffs
- New CEO Mike Nassif outlined a strategic plan for Neogen focusing on top-line growth, right-sizing the cost base, reinvigorating innovation, and deleveraging.
- For Q1 2026, Neogen reported revenues of $209 million, with core revenue remaining flat. Adjusted EBITDA was $35.5 million (17% margin), and adjusted EPS was $0.04.
- The company initiated a global headcount reduction of approximately 10% to achieve an annualized operating expense reduction of approximately $20 million, with an estimated $12 million benefit in fiscal year 2026.
- Neogen completed the divestiture of its Cleaners and Disinfectants business, generating approximately $115 million in net proceeds, which was used to pay down $100 million in debt.
- Management reaffirmed its full-year fiscal 2026 guidance, anticipating margin improvement throughout the year due to expected operational efficiencies and cost reduction benefits.
Oct 9, 2025, 12:00 PM
NEOGEN Announces First-Quarter 2026 Results
NEOG
Earnings
Guidance Update
CEO Change
- For the first quarter ended August 31, 2025, NEOGEN reported revenue of $209.2 million, a 3.6% decrease compared to the prior year, with Adjusted Net Income of $9.4 million and Adjusted EBITDA of $35.5 million.
- The company completed the divestiture of its Cleaners & Disinfectants business and used the net proceeds to repay $100.0 million of outstanding debt.
- Mike Nassif was welcomed as Chief Executive Officer and President effective August 11, 2025, and restructuring actions were implemented at the end of September to right-size the cost base.
- NEOGEN reaffirmed its full-year fiscal 2026 outlook, expecting revenue in the range of $820 million to $840 million and Adjusted EBITDA between $165 million and $175 million.
Oct 9, 2025, 11:02 AM
Neogen Announces First-Quarter 2026 Results and Reaffirms Full-Year Outlook
NEOG
Earnings
Management Change
Guidance Update
- Neogen reported Q1 FY26 revenue of $209.2 million, net income of $36.3 million, and Adjusted EBITDA of $35.5 million for the quarter ended August 31, 2025.
- The company completed the divestiture of its Cleaners & Disinfectants business, which facilitated the repayment of $100.0 million of debt, and welcomed Mike Nassif as Chief Executive Officer and President effective August 11.
- Neogen reaffirmed its full-year FY26 outlook, anticipating revenue in the range of $820 million to $840 million and Adjusted EBITDA between $165 million and $175 million.
- Gross margin for Q1 FY26 was 45.4%, a decrease from 48.4% in the prior year, and Adjusted EBITDA Margin was 17.0%, down from 20.1% in the prior-year period.
Oct 9, 2025, 11:00 AM
Neogen CFO and COO David Naemura to Depart by Year-End 2025
NEOG
CFO Change
Management Change
Executive Compensation
- Neogen Corporation's Chief Financial Officer and Chief Operating Officer, David Naemura, plans to resign by the end of 2025, with a transition period extending until after the company's Q3 filing in October.
- The company has engaged an executive search firm to find a new CFO and has a transition plan, including a bonus incentive for Naemura if he remains until December 31, 2025.
- Naemura's departure is not due to disagreements, and he earned $2.7 million in total compensation in the 2025 fiscal year.
- This leadership change occurs as Neogen faces significant financial challenges, including declining revenue and profitability, and a distressed Altman Z-Score.
Sep 15, 2025, 8:09 PM
Neogen announces CFO and COO David Naemura's resignation
NEOG
CFO Change
Management Change
Executive Compensation
- David Naemura, Neogen Corporation's Chief Financial Officer and Chief Operating Officer, communicated his intention to resign on September 12, 2025.
- His departure is expected between the filing of the Company's Form 10-Q in October and December 31, 2025, and is not due to any disagreements regarding company operations or financials.
- Mr. Naemura will receive 50% of his annual target cash bonus if he remains employed through December 31, 2025, to assist with the onboarding of his successor.
- Neogen has engaged an executive search firm to find a new Chief Financial Officer.
Sep 15, 2025, 8:09 PM
Neogen Corporation Faces Class Action Lawsuit Over Post-Merger Integration
NEOG
Legal Proceedings
Guidance Update
CEO Change
- Neogen Corporation (NASDAQ: NEOG) is subject to a class action lawsuit for investors who purchased securities between January 5, 2023, and June 3, 2025, with a lead plaintiff motion deadline of September 16, 2025.
- The lawsuit alleges that Neogen misrepresented the smooth integration of 3M's Food Safety Division, concealing significant operational and financial difficulties.
- The company made several disclosures revealing issues, including a $461 million non-cash goodwill impairment and downward revisions to full-year 2025 guidance on January 10, 2025.
- Further disclosures on April 9, 2025, included a Q3 net loss of $11 million, a 3.4% revenue decline, and the resignation of CEO John Adent.
- On June 4, 2025, Neogen disclosed an expected drop in its EBITDA margin to the "high-teens" from 22% due to elevated inventory write-offs.
Aug 29, 2025, 8:29 PM
Neogen Corporation Faces Securities Fraud Class Action
NEOG
Legal Proceedings
Profit Warning
Accounting Changes
- A class action lawsuit has been filed against Neogen Corporation (NASDAQ: NEOG).
- The lawsuit covers a class period from January 5, 2023, to June 3, 2025, with a lead plaintiff deadline of September 16, 2025.
- The complaint alleges that the integration with 3M was inefficient, necessitating a goodwill impairment and impacting capital expenditures, revenues, and EBITDA margins, and that the company's positive statements were materially misleading.
- Shareholders with losses of $100,000 or more are encouraged to contact the Law Offices of Howard G. Smith.
Aug 26, 2025, 4:00 PM
Neogen Corporation Faces Securities Fraud Class Action
NEOG
Legal Proceedings
- Neogen Corporation (NASDAQ: NEOG) is facing a class action lawsuit.
- The class period for Neogen's lawsuit is from January 5, 2023, to June 3, 2025.
- The lead plaintiff deadline for the Neogen class action is September 16, 2025.
- The complaint alleges that the integration with 3M was inefficient, which would necessitate a goodwill impairment and impact capital expenditures, revenues, and EBITDA margins, making the Company's positive statements materially misleading.
Aug 20, 2025, 5:00 PM
Class Action Lawsuits Filed Against Neogen, RxSight, Easterly ROCMuni, and Fiserv
NEOG
Legal Proceedings
Profit Warning
Accounting Changes
- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed against Neogen Corporation (NEOG), RxSight, Inc. (RXST), Easterly ROCMuni High Income Municipal Bond Fund (RMHIX, RMHVX, RMJAX), and Fiserv, Inc. (FI).
- The lead plaintiff deadline for Neogen Corporation is September 16, 2025, while for RxSight, Inc., Easterly ROCMuni High Income Municipal Bond Fund, and Fiserv, Inc., it is September 22, 2025.
- The complaints allege that defendants made false and/or misleading statements and/or failed to disclose material information, including issues such as inefficient integration with 3M for NEOG, "adoption challenges" and overstated demand for RXST, artificially inflated asset prices and flawed valuation methodology for Easterly ROCMuni, and unsustainable revenue growth from forced merchant migrations for Fiserv.
Aug 12, 2025, 4:00 PM
Quarterly earnings call transcripts for NEOGEN.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more